HTLV-III seroconversion associated with heat-treated factor VIII concentrate

The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells.

Mucosal immunology·2015

Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women.

Mucosal immunology·2014

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.

Mucosal immunology·2013

Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants.

Journal of virology·2009

Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy.

AIDS research and human retroviruses·2002

Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization.

Journal of immunology (Baltimore, Md. : 1950)·2001

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

How Biologics Are Changing the Global Burden of Inflammatory Bowel Disease: A Review.

Cureus·2026

The importance of B cells for osteogenic homeostasis.

Cell communication and signaling : CCS·2026

Leveraging chimeric antigen receptor-T cell therapy for the treatment of multiple sclerosis: Bridging oncology and neurology.

Current research in translational medicine·2026

Early Effect of Intravitreal Faricimab on Hard Exudates in Diabetic Macular Oedema.

Ophthalmology and therapy·2026

Double activation and low IL-2 manufacturing protocol increase expansion of healthy and patient-derived CAR-Tregs.

Molecular therapy. Advances·2026

A robust and scalable immunoadsorbent platform based on the high-affinity M03-IgG antibody for targeted IL-6 Removal in cytokine storm.

Frontiers in immunology·2026

Related Experiment Videos

HTLV-III seroconversion associated with heat-treated factor VIII concentrate

Related Concept Videos

The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells.

Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women.

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.

Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants.

Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy.

Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

How Biologics Are Changing the Global Burden of Inflammatory Bowel Disease: A Review.

The importance of B cells for osteogenic homeostasis.

Leveraging chimeric antigen receptor-T cell therapy for the treatment of multiple sclerosis: Bridging oncology and neurology.

Early Effect of Intravitreal Faricimab on Hard Exudates in Diabetic Macular Oedema.

Double activation and low IL-2 manufacturing protocol increase expansion of healthy and patient-derived CAR-Tregs.

A robust and scalable immunoadsorbent platform based on the high-affinity M03-IgG antibody for targeted IL-6 Removal in cytokine storm.

Related Experiment Videos

HTLV-III seroconversion associated with heat-treated factor VIII concentrate

Related Concept Videos

Related Articles